Pfizer Inc. (PFE) is considered a cheap NYSE stock to invest in by hedge funds

From Yahoo Finance: 2025-04-11 16:35:00

In a recent article, Pfizer Inc. (NYSE:PFE) is highlighted among other cheap NYSE stocks favored by hedge funds. JPMorgan’s Jack Caffrey emphasized diversified portfolios and the importance of ‘time in the market’ over ‘timing the market’. Market trends are driven by earnings rather than valuation, with opportunities in overlooked sectors like energy.

Pfizer Inc. (NYSE:PFE) stands out as a biopharmaceutical powerhouse with a forward P/E ratio of 7.7 and 92 hedge fund holders. The company offers a range of medicines and vaccines, including treatments for cardiovascular, infectious diseases, and COVID-19. Its oncology segment is thriving, with leading treatments for various cancers and ongoing trials for new therapies.

Ranked 9th on the list of cheap NYSE stocks to invest in according to hedge funds, Pfizer Inc. (NYSE:PFE) shows promise, but AI stocks are believed to offer higher returns in a shorter timeframe. Investors are encouraged to explore opportunities in AI stocks that may deliver significant gains. Pfizer Inc.’s commitment to innovation and strong financial performance make it a solid choice, but the potential of AI stocks is worth considering for substantial returns.



Read more at Yahoo Finance: Is Pfizer Inc. (PFE) A Cheap NYSE Stock to Invest in According to Hedge Funds?